{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:22:20Z","timestamp":1791861740592,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05189-y","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:26:33Z","timestamp":1769048793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perceived impact of medicinal cannabis on pelvic pain and endometriosis related symptoms in Aotearoa New Zealand: an observational cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Claire","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Semprini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Mikocka-Walus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"11","key":"5189_CR1","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","volume":"184","author":"PTK Saunders","year":"2021","unstructured":"Saunders PTK, Horne AW. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):2807\u201324.","journal-title":"Cell"},{"issue":"4","key":"5189_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/1471-0528.16447","volume":"128","author":"IJ Rowlands","year":"2021","unstructured":"Rowlands IJ, Abbott JA, Montgomery GW, Hockey R, Rogers P, Mishra GD. Prevalence and incidence of endometriosis in Australian women: a data linkage cohort study. BJOG. 2021;128(4):657\u201365.","journal-title":"BJOG"},{"issue":"1","key":"5189_CR3","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1038\/s41598-022-08464-x","volume":"12","author":"J Tewhaiti-Smith","year":"2022","unstructured":"Tewhaiti-Smith J, Semprini A, Bush D, Anderson A, Eathorne A, Johnson N, et al. An Aotearoa new Zealand survey of the impact and diagnostic delay for endometriosis and chronic pelvic pain. Sci Rep. 2022;12(1):4425.","journal-title":"Sci Rep"},{"issue":"1","key":"5189_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","volume":"4","author":"KT Zondervan","year":"2018","unstructured":"Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigan\u00f2 P, Endometriosis. Nat Reviews Disease Primers. 2018;4(1):9.","journal-title":"Nat Reviews Disease Primers"},{"issue":"6","key":"5189_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.fertnstert.2006.11.051","volume":"87","author":"N Sinaii","year":"2007","unstructured":"Sinaii N, Cleary SD, Younes N, Ballweg ML, Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277\u201386.","journal-title":"Fertil Steril"},{"issue":"12","key":"5189_CR6","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/imj.15494","volume":"52","author":"S Evans","year":"2022","unstructured":"Evans S, Villegas V, Dowding C, Druitt M, O\u2019Hara R, Mikocka-Walus A. Treatment use and satisfaction in Australian women with endometriosis: a mixed-methods study. Intern Med J. 2022;52(12):2096\u2013106.","journal-title":"Intern Med J"},{"issue":"4","key":"5189_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ajo.13699","volume":"63","author":"M Armour","year":"2023","unstructured":"Armour M, Ciccia D, Yazdani A, Rombauts L, Niekerk LV, Schubert R, et al. Endometriosis research priorities in Australia. Aust N Z J Obstet Gynaecol. 2023;63(4):594\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"5189_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/agh110","volume":"40","author":"F Rodr\u00edguez de Fonseca","year":"2005","unstructured":"Rodr\u00edguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M. The endocannabinoid system: physiology and Pharmacology. Alcohol Alcohol (Oxf Oxfs). 2005;40(1):2\u201314.","journal-title":"Alcohol Alcohol (Oxf Oxfs)"},{"issue":"1","key":"5189_CR9","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-12-0182","volume":"50","author":"AM Di Blasio","year":"2013","unstructured":"Di Blasio AM, Vignali M, Gentilini D. The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol. 2013;50(1):R1\u20139.","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"5189_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.pain.2010.08.037","volume":"151","author":"N Dmitrieva","year":"2010","unstructured":"Dmitrieva N, Nagabukuro H, Resuehr D, Zhang G, McAllister SL, McGinty KA, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151(3):703\u201310.","journal-title":"Pain"},{"key":"5189_CR11","doi-asserted-by":"crossref","unstructured":"Escudero-Lara A, Argerich J, Caba\u00f1ero D, Maldonado R. Disease-modifying effects of natural \u22069-tetrahydrocannabinol in endometriosis-associated pain. eLife. 2020;9e50356.","DOI":"10.7554\/eLife.50356"},{"issue":"1","key":"5189_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/can.2016.0035","volume":"2","author":"J Bouaziz","year":"2017","unstructured":"Bouaziz J, Bar On A, Seidman DS, Soriano D. The clinical significance of endocannabinoids in endometriosis pain management. Cannabis Cannabinoid Res. 2017;2(1):72\u201380.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"5189_CR13","first-page":"813","volume":"17","author":"M Bifulco","year":"2007","unstructured":"Bifulco M, Laezza C, Gazzerro P, Pentimalli F. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). Oncol Rep. 2007;17(4):813\u20136.","journal-title":"Oncol Rep"},{"issue":"5","key":"5189_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.acthis.2017.05.005","volume":"119","author":"E Bilgic","year":"2017","unstructured":"Bilgic E, Guzel E, Kose S, Aydin MC, Karaismailoglu E, Akar I, et al. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis. Acta Histochem. 2017;119(5):523\u201332.","journal-title":"Acta Histochem"},{"issue":"8","key":"5189_CR15","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.fertnstert.2010.02.006","volume":"93","author":"D Gentilini","year":"2010","unstructured":"Gentilini D, Besana A, Vigano P, Dalino P, Vignali M, Melandri M, et al. Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1\/2 pathways. Fertil Steril. 2010;93(8):2588\u201393.","journal-title":"Fertil Steril"},{"issue":"6","key":"5189_CR16","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2353\/ajpath.2010.100375","volume":"177","author":"M Leconte","year":"2010","unstructured":"Leconte M, Nicco C, Ng\u00f4 C, Arkwright S, Ch\u00e9reau C, Guibourdenche J, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol. 2010;177(6):2963\u201370.","journal-title":"Am J Pathol"},{"issue":"10","key":"5189_CR17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","volume":"30","author":"M Armour","year":"2021","unstructured":"Armour M, Sinclair J, Noller G, Girling J, Larcombe M, Al-Dabbas MA, et al. Illicit cannabis usage as a management strategy in new Zealand women with endometriosis: an online survey. J Women\u2019s Health. 2021;30(10):1485\u201392.","journal-title":"J Women\u2019s Health"},{"issue":"5","key":"5189_CR18","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s00404-024-07652-6","volume":"310","author":"V Jasinski","year":"2024","unstructured":"Jasinski V, Voltolini Velho R, Sehouli J, Mechsner S. Cannabis use in endometriosis: the patients have their say-an online survey for German-speaking countries. Arch Gynecol Obstet. 2024;310(5):2673\u201380.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"5189_CR19","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.jmig.2019.09.682","volume":"26","author":"AE Reinert","year":"2019","unstructured":"Reinert AE, Hibner M. Self-Reported efficacy of cannabis for endometriosis pain. J Minim Invasive Gynecol. 2019;26(7):S72.","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"5189_CR20","first-page":"256","volume":"42","author":"J Sinclair","year":"2020","unstructured":"Sinclair J, Smith CA, Abbott J, Chalmers KJ, Pate DW, Armour M. Cannabis Use, a Self-Management strategy among Australian women with endometriosis: results from a National online Survey. Journal of obstetrics and gynaecology canada: JOGC\u2009=\u2009Journal d\u2019obstetrique. Et Gynecologie Du Can : JOGC. 2020;42(3):256\u201361.","journal-title":"Et Gynecologie Du Can : JOGC"},{"issue":"17","key":"5189_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40265-023-01951-z","volume":"83","author":"J Sinclair","year":"2023","unstructured":"Sinclair J, Abbott J, Proudfoot A, Armour M. The place of cannabinoids in the treatment of gynecological pain. Drugs. 2023;83(17):1571\u20139.","journal-title":"Drugs"},{"issue":"4","key":"5189_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/can.2021.0116","volume":"7","author":"J Sinclair","year":"2021","unstructured":"Sinclair J, Toufaili Y, Gock S, Pegorer AG, Wattle J, Franke M, et al. Cannabis use for endometriosis: clinical and legal challenges in Australia and new Zealand. Cannabis Cannabinoid Res. 2021;7(4):464\u201372.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1155","key":"5189_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/postgradmedj-2020-139013","volume":"98","author":"K Oldfield","year":"2022","unstructured":"Oldfield K, Eathorne A, Tewhaiti-Smith J, Beasley R, Semprini A, Braithwaite I. Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of new Zealand Doctors in an oncology setting. Postgrad Med J. 2022;98(1155):35\u201342.","journal-title":"Postgrad Med J"},{"issue":"1","key":"5189_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12913-022-09021-y","volume":"23","author":"V Withanarachchie","year":"2023","unstructured":"Withanarachchie V, Rychert M, Wilkins C. The role of cannabis clinics in the health system: a qualitative study of physicians\u2019 views in new Zealand. BMC Health Serv Res. 2023;23(1):10.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"5189_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1023\/B:QURE.0000021316.79349.af","volume":"13","author":"G Jones","year":"2004","unstructured":"Jones G, Jenkinson C, Kennedy S. Evaluating the responsiveness of the endometriosis health profile questionnaire: the EHP-30. Qual Life Res. 2004;13(3):705\u201313.","journal-title":"Qual Life Res"},{"key":"5189_CR26","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Conceptual and design thinking for thematic analysis. Qualitative psychology. 2022;9(1):3.","DOI":"10.1037\/qup0000196"},{"issue":"1","key":"5189_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000515069","volume":"4","author":"S Jugl","year":"2021","unstructured":"Jugl S, Okpeku A, Costales B, Morris EJ, Alipour-Haris G, Hincapie-Castillo JM, et al. A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids. 2021;4(1):21\u201342.","journal-title":"Med Cannabis Cannabinoids"},{"key":"5189_CR28","doi-asserted-by":"publisher","first-page":"111263","DOI":"10.1016\/j.drugalcdep.2024.111263","volume":"257","author":"D Dawson","year":"2024","unstructured":"Dawson D, Stjepanovi\u0107 D, Lorenzetti V, Cheung C, Hall W, Leung J. The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis. Drug Alcohol Depend. 2024;257:111263.","journal-title":"Drug Alcohol Depend"},{"key":"5189_CR29","doi-asserted-by":"publisher","first-page":"100275","DOI":"10.1016\/j.rcsop.2023.100275","volume":"10","author":"S Jankie","year":"2023","unstructured":"Jankie S, Sewdass K, Smith W, Naraynsingh C, Johnson J, Farnon N, et al. A cross-sectional survey of prospective healthcare professionals\u2019 knowledge, attitudes and perceptions of medical cannabis. Exploratory Res Clin Social Pharm. 2023;10:100275.","journal-title":"Exploratory Res Clin Social Pharm"},{"issue":"7","key":"5189_CR30","doi-asserted-by":"publisher","first-page":"e022101","DOI":"10.1136\/bmjopen-2018-022101","volume":"8","author":"EA Karanges","year":"2018","unstructured":"Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey. BMJ Open. 2018;8(7):e022101.","journal-title":"BMJ Open"},{"issue":"4","key":"5189_CR31","doi-asserted-by":"publisher","first-page":"e230049","DOI":"10.1530\/RAF-23-0049","volume":"4","author":"J Sinclair","year":"2023","unstructured":"Sinclair J, Abbott J, Mikocka-Walus A, Ng C, Sarris J, Evans S, et al. A glimmer of hope\u2019: perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and new Zealand people with endometriosis \u2013 a qualitative study. Reprod Fertility. 2023;4(4):e230049.","journal-title":"Reprod Fertility"},{"issue":"2","key":"5189_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/03036758.2020.1750435","volume":"50","author":"R Poulton","year":"2020","unstructured":"Poulton R, Kirsten R, Joseph B, John H, Reremoana T, Tuari P, et al. Patterns of recreational cannabis use in Aotearoa-New Zealand and their consequences: evidence to inform voters in the 2020 referendum. J Royal Soc New Z. 2020;50(2):348\u201365.","journal-title":"J Royal Soc New Z"},{"key":"5189_CR33","doi-asserted-by":"publisher","first-page":"103712","DOI":"10.1016\/j.drugpo.2022.103712","volume":"105","author":"C Wilkins","year":"2022","unstructured":"Wilkins C, Rychert M, Queirolo R, Lenton SR, Kilmer B, Fischer B, et al. Assessing options for cannabis law reform: A Multi-Criteria decision analysis (MCDA) with stakeholders in new Zealand. Int J Drug Policy. 2022;105:103712.","journal-title":"Int J Drug Policy"},{"key":"5189_CR34","doi-asserted-by":"crossref","unstructured":"Fischer B, Hall W. New Zealand\u2019s failed cannabis legalization referendum \u2013implications for cannabis policy reform. Lancet Regional Health \u2013 Western Pacific. 2021;7:100080.","DOI":"10.1016\/j.lanwpc.2020.100080"},{"issue":"3","key":"5189_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/pm\/pnaa396","volume":"22","author":"P Lucas","year":"2021","unstructured":"Lucas P, Boyd S, Milloy MJ, Walsh Z. Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: results of a large prospective study. Pain Med. 2021;22(3):727\u201339.","journal-title":"Pain Med"},{"key":"5189_CR36","doi-asserted-by":"publisher","first-page":"1135453","DOI":"10.3389\/fphar.2023.1135453","volume":"14","author":"SS Stith","year":"2023","unstructured":"Stith SS, Li X, Brockelman F, Keeling K, Hall B, Vigil JM. Understanding feeling high and its role in medical cannabis patient outcomes. Front Pharmacol. 2023;14:1135453.","journal-title":"Front Pharmacol"},{"issue":"2","key":"5189_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1071\/HC22122","volume":"15","author":"V Withanarachchie","year":"2023","unstructured":"Withanarachchie V, Rychert M, Wilkins C. Barriers and facilitators to prescribing medicinal cannabis in new Zealand. J Prim Health Care. 2023;15(2):135\u201346.","journal-title":"J Prim Health Care"},{"issue":"5","key":"5189_CR38","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1016\/j.jpainsymman.2025.02.371","volume":"69","author":"IG Corral","year":"2025","unstructured":"Corral IG, McGrath K, Kumar P, Bishop N, Kwiatkowski C, Patel N, et al. Barriers and benefits of subsidized medical cannabis in oncologic outpatient palliative care. J Pain Symptom Manag. 2025;69(5):e674\u20135.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"5189_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/hex.13642","volume":"26","author":"RE Olson","year":"2023","unstructured":"Olson RE, Smith A, Good P, Dudley M, Gurgenci T, Hardy J. What price do you put on your health?\u2019: medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer. Health Expect. 2023;26(1):160\u201371.","journal-title":"Health Expect"},{"key":"5189_CR40","doi-asserted-by":"publisher","first-page":"e36667","DOI":"10.2196\/36667","volume":"25","author":"S Khademi","year":"2023","unstructured":"Khademi S, Hallinan CM, Conway M, Bonomo Y. Using social media data to investigate public perceptions of cannabis as a medicine: narrative review. J Med Internet Res. 2023;25:e36667.","journal-title":"J Med Internet Res"},{"key":"5189_CR41","doi-asserted-by":"publisher","first-page":"991045","DOI":"10.3389\/fgwh.2022.991045","volume":"3","author":"K Ellis","year":"2022","unstructured":"Ellis K, Munro D, Wood R. The experiences of endometriosis patients with diagnosis and treatment in new Zealand. Front Global Women\u2019s Health. 2022;3:991045.","journal-title":"Front Global Women\u2019s Health"},{"issue":"4","key":"5189_CR42","doi-asserted-by":"publisher","first-page":"101003","DOI":"10.1016\/j.imr.2023.101003","volume":"12","author":"N Giese","year":"2023","unstructured":"Giese N, Kwon KK, Armour M. Acupuncture for endometriosis: A systematic review and meta-analysis. Integr Med Res. 2023;12(4):101003.","journal-title":"Integr Med Res"},{"issue":"8","key":"5189_CR43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/1471-0528.16157","volume":"127","author":"JMN Duffy","year":"2020","unstructured":"Duffy JMN, Hirsch M, Vercoe M, Abbott J, Barker C, Collura B, et al. A core outcome set for future endometriosis research: an international consensus development study. BJOG: Int J Obstet Gynecol. 2020;127(8):967\u201374.","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"1","key":"5189_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejogrb.2012.12.037","volume":"168","author":"TJ van de Burgt","year":"2013","unstructured":"van de Burgt TJ, Kluivers KB, Hendriks JC. Responsiveness of the Dutch endometriosis health Profile-30 (EHP-30) questionnaire. Eur J Obstet Gynecol Reprod Biol. 2013;168(1):92\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05189-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:04:02Z","timestamp":1771247042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-025-05189-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5189"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05189-y","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the declaration of Helsinki and was approved by Otago Health Ethics Committee, #H23\/026. All participants provide free and informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual data is submitted for publication, all data is de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Medleaf Therapeutics and Helius Therapeutics contributed funding to support this project. Medleaf Therapeutics partially funded participant vouchers ($2,000 total). Helius provided subsidised CBD oil to Cannaplus for participant prescriptions. Both companies were not in-volved in study design, analysis or manuscript preparation. JS Is currently employed at Australian Natural Therapeutics Group and formerly sat on the scientific advisory board for BioCeuticals. JS also sits on the board of the Australian Medic-inal Cannabis Association (pro bono) and the steering committee of Cannabis Clinicians Australia (pro bono).MA has received funds from the Victorian Government, philanthropic donors (Wilson Foundation), and industry partners (Cannim, OzMedicannGroup) for research related to medicinal cannabis, outside the submitted work. He is also a scientific advisory board member for Evolv Health. He is a guest editor for the special edition of BMC complementary medicine and therapy - Advances in cannabis and cannabinoid research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}